Skip to main content
Skip to navigation

U.K.’s Fraud Office, China Cooperating in GSK Bribery Investigation

By Roberta Holland2014-07-30T12:15:00

THIS IS MEMBERS-ONLY CONTENT

SINGLE MEMBERSHIP CORPORATE MEMBERSHIP

You are not logged in and do not have access to members-only content.

If you are already a registered user or a member, SIGN IN now.

Related articles

Blog
SFO faces criticism for closing Rolls-Royce, GSK cases

2019-02-22T11:30:00Z By Jaclyn Jaeger

The U.K. Serious Fraud Office closed two long-running bribery and corruption cases against Rolls-Royce and GlaxoSmithKline—a decision that casts further doubt around the effectiveness of the SFO’s investigatory powers and makes companies question the purpose of entering a deferred prosecution agreement at all.
Article
Far East: The Epicenter of FCPA Enforcement?

2015-05-05T14:30:00Z By Jaclyn Jaeger

Image: Everyone says bribery risk is highest along the Pacific Rim, but how acute is the problem really? Pretty bad, according to a Compliance Week review of recent FCPA enforcement actions—and the risks will only increase as more U.S. companies enter Asia and more Asian companies tap U.S. capital markets. ...
Article
Whistleblower Laws Abroad Remain Weak and Untested

2015-04-28T09:15:00Z By Jaclyn Jaeger

Image: What whistleblower protections exist overseas that are comparable to those under the Sarbanes-Oxley and Dodd-Frank Acts? Compliance Week did a spot-check of major countries, and the results of our round-the-world tour are inside. “There’s no country in the world whose whistleblower protection laws come close to what we’ve developed ...